Mechanistically, SHMT1 promotes ovarian cancer metastasis and progression by increasing Neu5Ac levels and upregulating the proinflammatory cytokines including IL-6 and IL-8 (Gupta et al., 2017). This evidence concerns the gene SHMT1 and ovarian carcinoma.